Neurobehavioral consequences of small molecule-drug immunosuppression
- 1 September 2015
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 96 (Pt A) , 83-93
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation (Sche 341/19-1, Sche 341/19-2)
This publication has 139 references indexed in Scilit:
- Translational approaches to treatment-induced symptoms in cancer patientsNature Reviews Clinical Oncology, 2012
- The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple SclerosisClinical Neuropharmacology, 2010
- Immunosuppressant Neurotoxicity in Rat Brain Models: Oxidative Stress and Cellular MetabolismChemical Research in Toxicology, 2010
- mTOR signaling: At the crossroads of plasticity, memory and diseaseTrends in Neurosciences, 2010
- A novel electrophysiological model of chemotherapy-induced cognitive impairments in miceNeuroscience, 2008
- Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidationNeurobiology of Learning and Memory, 2008
- S1P1 Receptor Signaling Overrides Retention Mediated by Gαi-Coupled Receptors to Promote T Cell EgressImmunity, 2008
- RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENTTransplantation, 1991
- Cyclosporine lowers seizure threshold in an experimental model of electroshock-induced seizures in Munich-Wistar ratsLife Sciences, 1990